CELZ

$0.00

(

0.00%

)
Quote details

stock

Creative Medical Technology Holdings Inc

NASDAQ | CELZ

3.13

USD

$0.00

(

0.00%

)

At Close (As of Oct 31, 2025)

$9.70M

Market Cap

-

P/E Ratio

-3.13

EPS

$6.90

52 Week High

$1.69

52 Week Low

HEALTHCARE

Sector

CELZ Chart

Recent Chart
Price Action

CELZ Technicals

Tags:

CELZ Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $6.6K
Total Revenue $11K
Cost Of Revenue $4.4K
Costof Goods And Services Sold $4.4K
Operating Income -$5.7M
Selling General And Administrative $3.2M
Research And Development $2.4M
Operating Expenses $5.8M
Investment Income Net -
Net Interest Income $250K
Interest Income $250K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $110K
Income Before Tax -$5.5M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$5.5M
Comprehensive Income Net Of Tax -
Ebit -$5.7M
Ebitda -$5.6M
Net Income -$5.5M

Revenue & Profitability

Earnings Performance

CELZ Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $6.7M
Total Current Assets $6.1M
Cash And Cash Equivalents At Carrying Value $5.9M
Cash And Short Term Investments $5.9M
Inventory $2.2K
Current Net Receivables -
Total Non Current Assets $534K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $531K
Intangible Assets Excluding Goodwill $531K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $193K
Other Non Current Assets -
Total Liabilities $328K
Total Current Liabilities $328K
Current Accounts Payable $274K
Deferred Revenue -
Current Debt -
Short Term Debt $14K
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $14K
Other Current Liabilities $40K
Other Non Current Liabilities -
Total Shareholder Equity $6.3M
Treasury Stock -
Retained Earnings -$65M
Common Stock $1.7K
Common Stock Shares Outstanding $1.5M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$5.3M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $110K
Capital Expenditures $200K
Change In Receivables -
Change In Inventory $4.4K
Profit Loss -
Cashflow From Investment $6.3M
Cashflow From Financing $1.5M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$175K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$5.5M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $6.6K
Total Revenue $11K
Cost Of Revenue $4.4K
Costof Goods And Services Sold $4.4K
Operating Income -$5.7M
Selling General And Administrative $3.2M
Research And Development $2.4M
Operating Expenses $5.8M
Investment Income Net -
Net Interest Income $250K
Interest Income $250K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $110K
Income Before Tax -$5.5M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$5.5M
Comprehensive Income Net Of Tax -
Ebit -$5.7M
Ebitda -$5.6M
Net Income -$5.5M

CELZ News

CELZ Profile

Creative Medical Technology Holdings Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Creative Medical Technology Holdings, Inc. (CELZ) is an innovative biotechnology company headquartered in Phoenix, Arizona, dedicated to advancing regenerative medicine through the development of cutting-edge adult stem cell therapies. The firm concentrates on critical sectors such as immunology, urology, orthopedics, and neurology, targeting unmet medical needs and striving to enhance patient outcomes. With a robust research pipeline and a commitment to leveraging the unique properties of stem cells, CELZ is well-positioned to lead transformative changes in treatment paradigms within the healthcare industry.

EPWK
+38.67%
$0.09
VHAI
0.00%
$0.00
YDKG
+26.13%
$0.05
HBIO
+41.09%
$0.63
WTO
+6.46%
$0.04
HKD
+73.37%
$2.93
MSAI
+31.81%
$1.74
INTS
-44.35%
$0.73
AMZN
+10.77%
$246.86
NVDA
+0.40%
$203.72
GETY
-0.74%
$1.99
PFE
+1.21%
$24.58
BURU
-3.40%
$0.32
BYND
-2.72%
$1.60
CTM
+20.93%
$1.24
NOK
-3.50%
$6.88
PLUG
+0.05%
$2.65
BTG
-10.67%
$4.35
ONDS
+1.00%
$6.35
DNN
-0.93%
$3.19
QS
+16.18%
$18.34
GLE
+32.35%
$0.86
AZI
+5.29%
$0.09
AXDX
-61.36%
$0.03
MSPR
-30.73%
$0.21
TSLA
+2.75%
$452.21
ACHR
+2.96%
$11.28
ASST
+4.80%
$1.26
ADTX
-9.70%
$0.06
GPUS
-8.51%
$0.39
NWL
-28.07%
$3.39
LAZR
-45.51%
$1.14
RIG
-1.79%
$3.83
T
+0.38%
$24.77
CJET
-10.12%
$0.04
AAPL
+0.11%
$271.71
BITF
-3.94%
$3.90
INTC
-0.46%
$39.97
F
+0.34%
$13.10
TGE
-29.75%
$1.18
ADAP
-15.14%
$0.05
RGTI
+3.63%
$44.06
NLSP
+2.97%
$0.76
SOFI
-0.42%
$28.90
AMD
-3.59%
$254.84
CERO
-94.68%
$0.09
META
-2.89%
$647.15
NIO
+2.87%
$7.21
PLTR
+2.85%
$200.10
MNOV
+37.82%
$1.64
DVLT
-5.61%
$2.52
CAN
+9.47%
$1.35
LUMN
-3.91%
$9.93
RMBL
+60.50%
$3.21
RANI
+39.24%
$2.01
ADD
-25.47%
$0.05
METU
-22.78%
$34.04
WULF
+2.76%
$15.23
CCL
+1.64%
$28.79
VALE
+1.72%
$12.09
TLRY
+4.26%
$1.34
RXRX
-2.30%
$5.52
AAL
+2.38%
$13.08
CMG
-3.25%
$31.47
SRM
+53.27%
$10.30
VZ
+1.86%
$39.68
JOBY
+4.23%
$17.25
GRAB
+0.25%
$5.99
RIVN
+2.05%
$13.25
SNAP
+1.77%
$7.73
BENF
-10.29%
$0.55
DFSC
+19.54%
$5.20
QUBT
+10.35%
$16.52
WBD
+4.02%
$22.48
ETHD
-7.34%
$3.91
WLGS
-5.57%
$0.04
QBTS
+2.63%
$37.06
GOOGL
-0.50%
$280.07
CIFR
+2.05%
$19.46
KDLY
-9.97%
$0.85
ETWO
0.00%
$3.30
APLD
+1.62%
$34.50
CABA
+38.25%
$3.41
RIOT
-7.91%
$19.42
BBD
-0.59%
$3.37
ABEV
+1.95%
$2.34
MARA
+1.04%
$17.94
NIVF
-32.27%
$0.73
BTBT
+1.24%
$3.58
IXHL
-3.04%
$0.39
NAKA
+6.09%
$0.90
AFMD
-34.94%
$0.18
IONZ
-7.11%
$3.40
CLF
+2.76%
$12.59
AMCR
+0.06%
$7.85
SOUN
+4.56%
$17.63
GOOG
-0.47%
$280.54
LAES
+6.14%
$7.31
UUUU
-5.04%
$20.72
KHC
+0.06%
$24.59
EPWK
+38.67%
$0.09
VHAI
0.00%
$0.00
YDKG
+26.13%
$0.05
HBIO
+41.09%
$0.63
WTO
+6.46%
$0.04
HKD
+73.37%
$2.93
MSAI
+31.81%
$1.74
INTS
-44.35%
$0.73
AMZN
+10.77%
$246.86
NVDA
+0.40%
$203.72
GETY
-0.74%
$1.99
PFE
+1.21%
$24.58
BURU
-3.40%
$0.32
BYND
-2.72%
$1.60
CTM
+20.93%
$1.24
NOK
-3.50%
$6.88
PLUG
+0.05%
$2.65
BTG
-10.67%
$4.35
ONDS
+1.00%
$6.35
DNN
-0.93%
$3.19
QS
+16.18%
$18.34
GLE
+32.35%
$0.86
AZI
+5.29%
$0.09
AXDX
-61.36%
$0.03
MSPR
-30.73%
$0.21
TSLA
+2.75%
$452.21
ACHR
+2.96%
$11.28
ASST
+4.80%
$1.26
ADTX
-9.70%
$0.06
GPUS
-8.51%
$0.39
NWL
-28.07%
$3.39
LAZR
-45.51%
$1.14
RIG
-1.79%
$3.83
T
+0.38%
$24.77
CJET
-10.12%
$0.04
AAPL
+0.11%
$271.71
BITF
-3.94%
$3.90
INTC
-0.46%
$39.97
F
+0.34%
$13.10
TGE
-29.75%
$1.18
ADAP
-15.14%
$0.05
RGTI
+3.63%
$44.06
NLSP
+2.97%
$0.76
SOFI
-0.42%
$28.90
AMD
-3.59%
$254.84
CERO
-94.68%
$0.09
META
-2.89%
$647.15
NIO
+2.87%
$7.21
PLTR
+2.85%
$200.10
MNOV
+37.82%
$1.64
DVLT
-5.61%
$2.52
CAN
+9.47%
$1.35
LUMN
-3.91%
$9.93
RMBL
+60.50%
$3.21
RANI
+39.24%
$2.01
ADD
-25.47%
$0.05
METU
-22.78%
$34.04
WULF
+2.76%
$15.23
CCL
+1.64%
$28.79
VALE
+1.72%
$12.09
TLRY
+4.26%
$1.34
RXRX
-2.30%
$5.52
AAL
+2.38%
$13.08
CMG
-3.25%
$31.47
SRM
+53.27%
$10.30
VZ
+1.86%
$39.68
JOBY
+4.23%
$17.25
GRAB
+0.25%
$5.99
RIVN
+2.05%
$13.25
SNAP
+1.77%
$7.73
BENF
-10.29%
$0.55
DFSC
+19.54%
$5.20
QUBT
+10.35%
$16.52
WBD
+4.02%
$22.48
ETHD
-7.34%
$3.91
WLGS
-5.57%
$0.04
QBTS
+2.63%
$37.06
GOOGL
-0.50%
$280.07
CIFR
+2.05%
$19.46
KDLY
-9.97%
$0.85
ETWO
0.00%
$3.30
APLD
+1.62%
$34.50
CABA
+38.25%
$3.41
RIOT
-7.91%
$19.42
BBD
-0.59%
$3.37
ABEV
+1.95%
$2.34
MARA
+1.04%
$17.94
NIVF
-32.27%
$0.73
BTBT
+1.24%
$3.58
IXHL
-3.04%
$0.39
NAKA
+6.09%
$0.90
AFMD
-34.94%
$0.18
IONZ
-7.11%
$3.40
CLF
+2.76%
$12.59
AMCR
+0.06%
$7.85
SOUN
+4.56%
$17.63
GOOG
-0.47%
$280.54
LAES
+6.14%
$7.31
UUUU
-5.04%
$20.72
KHC
+0.06%
$24.59

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.